THE EFFECT OF FUNCTIONAL PRODUCTS ON BIOMARKERS DIAGNOSING CARDIOVASCULAR DISEASES

Functional foods and their biologically active compounds have been widely studied as a group of foods of great importance for preventing the development of chronic diseases. Cardiovascular disease is a global health problem that can be alleviated with functional foods. The reduction in the risk of cardiovascular disease can be measured using specific biomarkers of cardiovascular disease, such as lipid profile, endothelial function, platelet activation, hemostasis and biomarkers of inflammation. Some functional biologically active compounds may play an important role in the prevention and treatment of cardiovascular diseases, beneficially affecting the levels of these biomarkers.

The purpose of this study was to study the effect of functional foods on biomarkers of cardiovascular diseases, as well as the possible improvement of indicators when taking a functional food mixture.

Methods: A literature search to identify articles was conducted using PubMed, Science Direct.

The results were analyzed in twenty-seven publications. In all these publications, the positive effect of functional products on biomarkers has been reported. Most often, positive results were noted from the use of soy products, dairy products, pomegranates, cranberries and vegetarian diets and the Okinawa diet.

1. Bekbergenova ZH.B. Rukovodstvo dlya meditsinskikh sester rasshirennoi praktiki po otsenke riska i profilaktike serdechno-sosudistykh zabolevanii / ZH.B. Bekbergenova, A.T. Umbetzhanova. – Nur-Sultan: Respublikanskii tsentr razvitiya zdravookhraneniya, 2019. – 72 s. (In Russian).

2. Hajjo R. Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers / R. Hajjo, D.A. Sabbah, A.Q.Al Bawab // Diagnostics. – 2022. – № 12(7). – R. 1742. https://doi.org/10.3390/diagnostics12071742. (In English).

3. Konstantinidi M. Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity's Metabolic Consequences. / M. Konstantinidi, E.A. Koutelidakis // Medicines (Basel). – 2019. – № 6(3)94. https://doi:10.3390/medicines6030094. (In English).

4. Halford J.C.G. Satiety-enhancing products for appetite control: science and regulation of functional foods for weight management / J.C.G. Halford, J.A. Harrold // Published online by Cambridge University Press. – 2012. http://doi:10.1017/S0029665112000134. (In English).

5. Antonios E.K. The effects of functional food and bioactive compounds on biomarkers of cardiovascular diseases / E.K. Antonios // Functional Foods Textbook. Martirosyan D. (Εd.). Functional Food Center, U.S.A. 1st Edition. – R. 89-117. (In English).

6. Kutelidakis A.E. The effect of functional foods and biologically active compounds on biomarkers of cardiovascular diseases / A.E. Kutelidakis // Center for Functional Nutrition, USA, 1st edition. – R. 89-117. (In English).

7. Gut health: predictive biomarkers for preventive medicine and development of functional foods / R. Oozeer et al // Published online by Cambridge University Press. – 2010. http://doi:10.1017/S0007114509993400. (In English).

8. Bjursell M.K. Gordon Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period / M.K. Bjursell, E.C. Martens, J.I. Gordon // J Biol Chem. – 2006. – № 281(47). http://doi:10.1074/jbc.M606509200. (In English).

9. Early differences in fecal microbiota composition in children may predict overweight / K.M. Collado et al // Am J Clin Nutr. – 2008. – № 87. – R. 534-538. (In English).

10. Obesity alters gut microbial ecology / R.E. Ley et al // Proc Natl Acad Sci USA. – 2008. – № 102. – R. 11070-11075. (In English).

11. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America / C.W. Yancy et al // Circulation. – 2017. – № 136(6). – R. e137–61. http://doi:10.1161/CIR.0000000000000509. (In English).

12. Jackson S.E. Personalized cancer medicine / S.E. Jackson, D.D. Chester // Int J Cancer. – 2015. – № 137(2). – R. 262-6. https://doi.org/10.1002/ijc.28940. (In English).

13. van Vollenhoven R.F. Personalized medicine in rheumatology / R.F. van Vollenhoven, M. L'ami, G. Wolbink // The Psychiatrist is a psychiatrist. – 2018. – № 60(3). – R. 146-50. (In English).

14. Narod S.A. Personalized medicine and public health: breast and ovarian cancer / S.A. Narod // Hum Genet. – 2018. – № 137(10). – R. 769-778. https://doi.org/10.1007/s0043 9-018-1944-6. (In English).

15. Changes in the human intestinal microbiome in cirrhosis of the liver / N. Qin et al // Nature. – 2014. – № 513(7516). – R. 59-64. https://doi.org/10.1038/natur e13568. (In English).